- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04538703
Social Media Use of Acne Vulgaris Patients: Multicenter, Survey Work
January 8, 2021 updated by: Melek Aslan Kayıran, Istanbul Medeniyet University
Acne Vulgaris is a chronic skin disease.
However, chronic and repetitive due to the quality of life and psychological status of patients can affect.
For this reason, patients carry out various research on their diseases on social media and follow programs on these issues in other media such as television and radio.
However, there is no study on how much patients are interested in these publications, how much they trust them, and how they reach and organize information via social media.
The aim of the study will be to clarify how and how patients with Acne Vulgaris use social media to obtain information about the diagnosis and treatment of their disease, the interaction of patient groups with each other, and how often social media is used, especially in which group of patients.
Study Overview
Study Type
Observational
Enrollment (Anticipated)
3000
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Istanbul, Turkey
- Recruiting
- Melek Aslan Kayıran
-
Contact:
- Melek Aslan Kayıran, M.D.
- Phone Number: +905325232873
- Email: melekaslan@gmail.com
-
Principal Investigator:
- Melek Aslan Kayıran, M.D.
-
Sub-Investigator:
- Ayşe Serap Karadağ, As. Prof.
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
12 years to 60 years (Child, Adult)
Accepts Healthy Volunteers
N/A
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
acne vulgaris patients between 12-60 years of age
Description
Inclusion Criteria:
- acne vulgaris patient
Exclusion Criteria:
- who does not want to answer the questions
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Social media use of acne vulgaris patients, a questionnaire will be asked the patients and try to learn how they use social media for getting information about their disease.
Time Frame: september 2020
|
september 2020
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 1, 2020
Primary Completion (Anticipated)
January 15, 2021
Study Completion (Anticipated)
January 30, 2021
Study Registration Dates
First Submitted
August 31, 2020
First Submitted That Met QC Criteria
August 31, 2020
First Posted (Actual)
September 4, 2020
Study Record Updates
Last Update Posted (Actual)
January 11, 2021
Last Update Submitted That Met QC Criteria
January 8, 2021
Last Verified
January 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IstanbulMU7
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Acne Vulgaris
-
Galderma R&DCompletedSevere Acne VulgarisUnited States, Canada, Puerto Rico
-
Sebacia, Inc.CompletedInflammatory Acne VulgarisUnited States
-
Nexgen Dermatologics, Inc.Unknown
-
Rejuva Medical AestheticsHealMD, LLCNot yet recruitingAcne Vulgaris (Disorder)United States
-
InMode MD Ltd.Active, not recruitingInflammatory Acne VulgarisUnited States
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingModerate to Severe Acne VulgarisChina
-
PollogenLumenis Be Ltd.RecruitingModerate to Severe Acne VulgarisUnited States
-
Boston PharmaceuticalsCompletedModerate to Severe Acne VulgarisUnited States, Canada
-
Bispebjerg HospitalCompleted
-
Actavis Mid-Atlantic LLCCompletedMILD TO SEVERE ACNE VULGARISIndia
Clinical Trials on acne vulgaris
-
Nantes University HospitalRecruiting
-
Istanbul Medeniyet UniversityCompleted
-
South Valley UniversityNot yet recruitingAcne Vulgaris
-
Chang Gung Memorial HospitalRecruiting
-
BiogenWithdrawn
-
Aalborg UniversityRecruitingSleep Deprivation | Histamine | CowhageDenmark
-
Next Science TMSkin Laser & Surgery SpecialistsTerminatedAcne VulgarisUnited States
-
Dr. Behnood AbbasiCompletedType 2 Diabetes MellitusIran, Islamic Republic of
-
Shahid Beheshti UniversityCompletedBlood Pressure | Cardiovascular Risk Factor | Lipid ProfileIran, Islamic Republic of
-
Johnson & Johnson Consumer Inc. (J&JCI)Completed